Artículos de revistas sobre el tema "MuscleBlind Like (MBNL)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "MuscleBlind Like (MBNL)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bargiela, Ariadna, Maria Sabater-Arcis, Jorge Espinosa-Espinosa, Miren Zulaica, Adolfo Lopez de Munain y Ruben Artero. "Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models". Proceedings of the National Academy of Sciences 116, n.º 50 (21 de noviembre de 2019): 25203–13. http://dx.doi.org/10.1073/pnas.1820297116.
Texto completoVoss, Dillon, Anthony Sloan, Eli Bar y Eli Bar. "TAMI-49. THE ALTERNATIVE SPLICING FACTOR MBNL1 INHIBITS GLIOBLASTOMA TUMOR INITIATION AND PROGRESSION BY REDUCING HYPOXIA-INDUCED STEMNESS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii223—ii224. http://dx.doi.org/10.1093/neuonc/noaa215.936.
Texto completoOverby, Sarah, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan Fernández-Costa, Jordina Balaguer-Trias et al. "BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice". Pharmaceutics 15, n.º 4 (31 de marzo de 2023): 1118. http://dx.doi.org/10.3390/pharmaceutics15041118.
Texto completoYadava, Ramesh S., Mahua Mandal y Mani S. Mahadevan. "Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration". International Journal of Molecular Sciences 25, n.º 5 (26 de febrero de 2024): 2687. http://dx.doi.org/10.3390/ijms25052687.
Texto completoGonzález, Àlex L., Daniel Fernández-Remacha, José Ignacio Borrell, Jordi Teixidó y Roger Estrada-Tejedor. "Cognate RNA-Binding Modes by the Alternative-Splicing Regulator MBNL1 Inferred from Molecular Dynamics". International Journal of Molecular Sciences 23, n.º 24 (18 de diciembre de 2022): 16147. http://dx.doi.org/10.3390/ijms232416147.
Texto completoVerbeeren, Jens, Joana Teixeira y Susana M. D. A. Garcia. "The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism". PLOS Genetics 19, n.º 12 (22 de diciembre de 2023): e1011109. http://dx.doi.org/10.1371/journal.pgen.1011109.
Texto completoTerenzi, Fulvia y Andrea N. Ladd. "Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity". RNA Biology 7, n.º 1 (enero de 2010): 43–55. http://dx.doi.org/10.4161/rna.7.1.10401.
Texto completoLópez-Martínez, Andrea, Patricia Soblechero-Martín, Laura de-la-Puente-Ovejero, Gisela Nogales-Gadea y Virginia Arechavala-Gomeza. "An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I". Genes 11, n.º 9 (22 de septiembre de 2020): 1109. http://dx.doi.org/10.3390/genes11091109.
Texto completoSznajder, Łukasz J. y Maurice S. Swanson. "Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy". International Journal of Molecular Sciences 20, n.º 13 (9 de julio de 2019): 3365. http://dx.doi.org/10.3390/ijms20133365.
Texto completoTanner, Matthew K., Zhenzhi Tang y Charles A. Thornton. "Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy". Nucleic Acids Research 49, n.º 4 (27 de enero de 2021): 2240–54. http://dx.doi.org/10.1093/nar/gkab022.
Texto completoLópez Castel, Arturo, Sarah Joann Overby y Rubén Artero. "MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy". International Journal of Molecular Sciences 20, n.º 22 (9 de noviembre de 2019): 5600. http://dx.doi.org/10.3390/ijms20225600.
Texto completoHolm, Frida, Eva Hellqvist, Cayla N. Mason, Shawn A. Ali, Nathaniel Delos-Santos, Christian L. Barrett, Hye-Jung Chun et al. "Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal". Proceedings of the National Academy of Sciences 112, n.º 50 (30 de noviembre de 2015): 15444–49. http://dx.doi.org/10.1073/pnas.1506943112.
Texto completoHuang, Hu, Karl J. Wahlin, Minda McNally, Natasha D. Irving y Ruben Adler. "Developmental regulation of muscleblind-like (MBNL) gene expression in the chicken embryo retina". Developmental Dynamics 237, n.º 1 (enero de 2008): 286–96. http://dx.doi.org/10.1002/dvdy.21408.
Texto completoTabaglio, Tommaso, Diana HP Low, Winnie Koon Lay Teo, Pierre Alexis Goy, Piotr Cywoniuk, Heike Wollmann, Jessica Ho et al. "MBNL1 alternative splicing isoforms play opposing roles in cancer". Life Science Alliance 1, n.º 5 (7 de septiembre de 2018): e201800157. http://dx.doi.org/10.26508/lsa.201800157.
Texto completoPenna, Matthew S., Rong-Chi Hu, George G. Rodney y Thomas A. Cooper. "The role ofLimch1alternative splicing in skeletal muscle function". Life Science Alliance 6, n.º 6 (28 de marzo de 2023): e202201868. http://dx.doi.org/10.26508/lsa.202201868.
Texto completoXie, Jianxin, Wei Zou, Madina Tugizova, Kang Shen y Xiangming Wang. "MBL-1 and EEL-1 affect the splicing and protein levels of MEC-3 to control dendrite complexity". PLOS Genetics 19, n.º 9 (20 de septiembre de 2023): e1010941. http://dx.doi.org/10.1371/journal.pgen.1010941.
Texto completoLi, Moyi, Yan Zhuang, Ranjan Batra, James D. Thomas, Mao Li, Curtis A. Nutter, Marina M. Scotti et al. "HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy". Proceedings of the National Academy of Sciences 117, n.º 10 (21 de febrero de 2020): 5472–77. http://dx.doi.org/10.1073/pnas.1907297117.
Texto completoStepniak-Konieczna, Ewa, Patryk Konieczny, Piotr Cywoniuk, Julia Dluzewska y Krzysztof Sobczak. "AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1". Nucleic Acids Research 48, n.º 5 (22 de enero de 2020): 2531–43. http://dx.doi.org/10.1093/nar/gkaa007.
Texto completoWang, Eric T., Daniel Treacy, Katy Eichinger, Adam Struck, Joseph Estabrook, Hailey Olafson, Thomas T. Wang et al. "Transcriptome alterations in myotonic dystrophy skeletal muscle and heart". Human Molecular Genetics 28, n.º 8 (17 de diciembre de 2018): 1312–21. http://dx.doi.org/10.1093/hmg/ddy432.
Texto completoHolm, Frida Linnea, Eva Hellqvist, Cayla N. Mason, Shawn Ali, Nathaniel Delos Santos, Christian Barrett, Hye-Jung Chun et al. "Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal". Blood 126, n.º 23 (3 de diciembre de 2015): 1227. http://dx.doi.org/10.1182/blood.v126.23.1227.1227.
Texto completoIhsan, M. O., D. M. Tan, U. Muniasamy, M. S. Ong, X. Y. Lin, C. N. Lee, R. Dorajoo y V. Sorokin. "Muscleblind-like (MBNL) protein family overexpression lead to pro-synthetic phenotype modulation of arterial human vascular smooth muscle cells in diabetes mellitus". Atherosclerosis 355 (agosto de 2022): 205–6. http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.821.
Texto completoJu, Woong, Hye Youn Sung y Jung-Hyuck Ahn. "Abstract B091: Overexpression of Muscleblind Like Splicing Regulator 2 (MBNL2) enhances cisplatin resistance in ovarian cancer". Molecular Cancer Therapeutics 22, n.º 12_Supplement (1 de diciembre de 2023): B091. http://dx.doi.org/10.1158/1535-7163.targ-23-b091.
Texto completoChen, Jiaorong, Jiaqi Wang, Jingyi Qian, Mengying Bao, Xin Zhang y Zheng Huang. "MBNL1 Suppressed Cancer Metastatic of Skin Squamous Cell Carcinoma Via by TIAL1/MYOD1/Caspase-9/3 Signaling Pathways". Technology in Cancer Research & Treatment 20 (1 de enero de 2021): 153303382096075. http://dx.doi.org/10.1177/1533033820960755.
Texto completoTran, Hélène, Nathalie Gourrier, Camille Lemercier-Neuillet, Claire-Marie Dhaenens, Audrey Vautrin, Francisco José Fernandez-Gomez, Ludovic Arandel et al. "Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms". Journal of Biological Chemistry 286, n.º 18 (18 de marzo de 2011): 16435–46. http://dx.doi.org/10.1074/jbc.m110.194928.
Texto completoCheng, Albert W., Jiahai Shi, Piu Wong, Katherine L. Luo, Paula Trepman, Eric T. Wang, Heejo Choi, Christopher B. Burge y Harvey F. Lodish. "Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis". Blood 124, n.º 4 (24 de julio de 2014): 598–610. http://dx.doi.org/10.1182/blood-2013-12-542209.
Texto completoSun, Xueqin, Xinghua Diao, Xiaolin Zhu, Xuexue Yin y Guangying Cheng. "Nanog-mediated stem cell properties are critical for MBNL3-associated paclitaxel resistance of ovarian cancer". Journal of Biochemistry 169, n.º 6 (18 de febrero de 2021): 747–56. http://dx.doi.org/10.1093/jb/mvab021.
Texto completoGates, Devika P., Leslie A. Coonrod y J. Andrew Berglund. "Autoregulated Splicing of muscleblind-like 1 (MBNL1) Pre-mRNA". Journal of Biological Chemistry 286, n.º 39 (9 de agosto de 2011): 34224–33. http://dx.doi.org/10.1074/jbc.m111.236547.
Texto completoCai, Jin, Ningchao Wang, Guanglan Lin, Haowei Zhang, Weidong Xie, Yaou Zhang y Naihan Xu. "MBNL2 Regulates DNA Damage Response via Stabilizing p21". International Journal of Molecular Sciences 22, n.º 2 (14 de enero de 2021): 783. http://dx.doi.org/10.3390/ijms22020783.
Texto completoLi, Yanbing, Min Zong, Xiaonan Guan, Xuejiao Wu, Guiling Ma, Yu Wei y Zhi Li. "MBNL1-AS1 Promotes Hypoxia-Induced Myocardial Infarction via the miR-132-3p/RAB14/CAMTA1 Axis". Oxidative Medicine and Cellular Longevity 2023 (4 de febrero de 2023): 1–12. http://dx.doi.org/10.1155/2023/3308725.
Texto completoYokoyama, Shingo, Yoshitaka Ohno, Tatsuro Egawa, Kazuya Ohashi, Rika Ito, Huascar Pedro Ortuste Quiroga, Tomohiro Yamashita y Katsumasa Goto. "MBNL1-Associated Mitochondrial Dysfunction and Apoptosis in C2C12 Myotubes and Mouse Skeletal Muscle". International Journal of Molecular Sciences 21, n.º 17 (2 de septiembre de 2020): 6376. http://dx.doi.org/10.3390/ijms21176376.
Texto completoHao, Minqi, Kevan Akrami, Ke Wei, Carlos De Diego, Nam Che, Jeong-Hee Ku, James Tidball, Michael C. Graves, Perry B. Shieh y Fabian Chen. "Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy". Developmental Dynamics 237, n.º 2 (21 de enero de 2008): 403–10. http://dx.doi.org/10.1002/dvdy.21428.
Texto completoSeachrist, Darcie D., Molly M. Hannigan, Natasha N. Ingles, Bryan M. Webb, Kristen L. Weber-Bonk, Peng Yu, Gurkan Bebek et al. "The transcriptional repressor BCL11A promotes breast cancer metastasis". Journal of Biological Chemistry 295, n.º 33 (23 de junio de 2020): 11707–19. http://dx.doi.org/10.1074/jbc.ra120.014018.
Texto completoTeplova, Marianna y Dinshaw J. Patel. "Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1". Nature Structural & Molecular Biology 15, n.º 12 (30 de noviembre de 2008): 1343–51. http://dx.doi.org/10.1038/nsmb.1519.
Texto completoLee, Johanna E. y Thomas A. Cooper. "Pathogenic mechanisms of myotonic dystrophy". Biochemical Society Transactions 37, n.º 6 (19 de noviembre de 2009): 1281–86. http://dx.doi.org/10.1042/bst0371281.
Texto completoRamon-Duaso, Carla, Thomas Gener, Marta Consegal, Cristina Fernández-Avilés, Juan José Gallego, Laura Castarlenas, Maurice S. Swanson et al. "Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression". Cerebral Cortex 29, n.º 7 (27 de julio de 2018): 2978–97. http://dx.doi.org/10.1093/cercor/bhy164.
Texto completoBallester-Lopez, Alfonsina, Judit Núñez-Manchón, Emma Koehorst, Ian Linares-Pardo, Miriam Almendrote, Giuseppe Lucente, Nicolau Guanyabens et al. "Three-dimensional imaging in myotonic dystrophy type 1". Neurology Genetics 6, n.º 4 (21 de julio de 2020): e484. http://dx.doi.org/10.1212/nxg.0000000000000484.
Texto completoSmith, Kelly P., Meg Byron, Carol Johnson, Yigong Xing y Jeanne B. Lawrence. "Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains". Journal of Cell Biology 178, n.º 6 (10 de septiembre de 2007): 951–64. http://dx.doi.org/10.1083/jcb.200706048.
Texto completoHerrendorff, Ruben, Maria Teresa Faleschini, Adeline Stiefvater, Beat Erne, Tatiana Wiktorowicz, Frances Kern, Matthias Hamburger, Olivier Potterat, Jochen Kinter y Michael Sinnreich. "Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I". Journal of Biological Chemistry 291, n.º 33 (13 de junio de 2016): 17165–77. http://dx.doi.org/10.1074/jbc.m115.710616.
Texto completoNeault, Nafisa, Aymeric Ravel-Chapuis, Stephen D. Baird, John A. Lunde, Mathieu Poirier, Emiliyan Staykov, Julio Plaza-Diaz et al. "Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model". International Journal of Molecular Sciences 24, n.º 4 (14 de febrero de 2023): 3794. http://dx.doi.org/10.3390/ijms24043794.
Texto completoLee, Kyung-Soon, Yi Cao, Hanna E. Witwicka, Susan Tom, Stephen J. Tapscott y Edith H. Wang. "RNA-binding Protein Muscleblind-like 3 (MBNL3) Disrupts Myocyte Enhancer Factor 2 (Mef2) β-Exon Splicing". Journal of Biological Chemistry 285, n.º 44 (13 de agosto de 2010): 33779–87. http://dx.doi.org/10.1074/jbc.m110.124255.
Texto completoNeault, Nafisa, Sean O’Reilly, Aiman Tariq Baig, Julio Plaza-Diaz, Mehrdad Azimi, Faraz Farooq, Stephen D. Baird y Alex MacKenzie. "High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)". PLOS ONE 16, n.º 9 (14 de septiembre de 2021): e0256276. http://dx.doi.org/10.1371/journal.pone.0256276.
Texto completoGurunathan, Arun, Lana S. Itskovich, Jason Clark, Matthew Burwinkel, Nathan Salomonis, Meenakshi Venkatasubramanian, Kashish Chetal, Lynn Lee y Ashish R. Kumar. "MLL-Fusion Leukemia Dependence on MBNL1 Is Associated with Alternative Splicing of Oncogenic Proteins". Blood 132, Supplement 1 (29 de noviembre de 2018): 3883. http://dx.doi.org/10.1182/blood-2018-99-112349.
Texto completoItskovich, Svetlana S., Jason Clark, James C. Mulloy, Matthew D. Disney y Ashish R. Kumar. "MBNL1 As a New Therapeutic Target in MLL-Fusion Gene Leukemia". Blood 126, n.º 23 (3 de diciembre de 2015): 462. http://dx.doi.org/10.1182/blood.v126.23.462.462.
Texto completoAngelbello, Alicia J., Suzanne G. Rzuczek, Kendra K. Mckee, Jonathan L. Chen, Hailey Olafson, Michael D. Cameron, Walter N. Moss, Eric T. Wang y Matthew D. Disney. "Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model". Proceedings of the National Academy of Sciences 116, n.º 16 (29 de marzo de 2019): 7799–804. http://dx.doi.org/10.1073/pnas.1901484116.
Texto completoSen, Supriya, Indrani Talukdar, Ying Liu, Joseph Tam, Sita Reddy y Nicholas J. G. Webster. "Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer". Journal of Biological Chemistry 285, n.º 33 (2 de junio de 2010): 25426–37. http://dx.doi.org/10.1074/jbc.m109.095224.
Texto completodeLorimier, Elaine, Melissa N. Hinman, Jeremy Copperman, Kausiki Datta, Marina Guenza y J. Andrew Berglund. "Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility". Journal of Biological Chemistry 292, n.º 10 (27 de enero de 2017): 4350–57. http://dx.doi.org/10.1074/jbc.m116.770768.
Texto completoLueck, John D., Ami Mankodi, Maurice S. Swanson, Charles A. Thornton y Robert T. Dirksen. "Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy". Journal of General Physiology 129, n.º 1 (11 de diciembre de 2006): 79–94. http://dx.doi.org/10.1085/jgp.200609635.
Texto completoLiu, Weifeng, Wenyuan Lin y Liangliang Yu. "Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) axis". Bioengineered 13, n.º 1 (1 de enero de 2022): 1424–35. http://dx.doi.org/10.1080/21655979.2021.2018974.
Texto completoFrison-Roche, Charles, Célia Martin Demier, Steve Cottin, Jeanne Lainé, Ludovic Arandel, Marius Halliez, Mégane Lemaitre et al. "MBNL deficiency in motor neurons disrupts neuromuscular junction maintenance and gait coordination". Brain, 26 de octubre de 2024. http://dx.doi.org/10.1093/brain/awae336.
Texto completoHildebrandt, Ryan P., Kathryn R. Moss, Aleksandra Janusz-Kaminska, Luke A. Knudson, Lance T. Denes, Tanvi Saxena, Devi Prasad Boggupalli et al. "Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes". Nature Communications 14, n.º 1 (9 de junio de 2023). http://dx.doi.org/10.1038/s41467-023-38923-6.
Texto completo